Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantationSascha Dietrich, H Finel, Carmen Martı́nez et al.|Leukemia|2016Cited by 44
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Eva González‐Barca, Anna Sureda, Ariane Boumendil et al.|Bone Marrow Transplantation|2019Cited by 43
S225: ALLOGENEIC STEM CELL TRANSPLANTATION FOR NK/T-CELL LYMPHOMA IN THE ERA OF ASPARAGINASE-BASED CHEMOTHERAPY: A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTYPhilipp Berning, Bertram Glaß, Feng‐Rong Wang et al.|HemaSphere|2023Cited by 0